CNSP

CNS PHARMACEUTICALS INC

CNSP·18978H102·US·Common Stock·Healthcare - Biotechnology

CNSP (CNS PHARMACEUTICALS INC) is held by 5 institutional investors as of Q2 2026. Largest holders: VANGUARD FIDUCIARY TRUST CO ($48,880), VANGUARD CAPITAL MANAGEMENT LLC ($33,427), UBS Group AG ($6,983). Net institutional sentiment: Mixed.

5
Holders
$89,386
Total Value
57% (7)
Consensus
4 buying - 3 selling
13F: Insider & Congress: Updated regularly
CNSP

Smart Money Verdict

View all
Loading verdict
Held by 5 funds

Who's Trading

Source dates: Price Oct 13, 2026 · Insiders Aug 18, 2026 · Activists none · Congress none

InsiderLRLevin RamiExercise 5K shAug 14, 2026
InsiderCLCharles Faith L.Buy $34KMay 18, 2026
InsiderFMFisher MichalBuy $10KMay 18, 2026

Top Holders

Checking access…
Action
New
10,226$48,8800.0%+8.58%
31
New
6,993$33,4270.0%+8.58%
30
Increased
1,461(+100.4%)$6,9830.0%—
18
New
19$910.0%+8.58%
17
Unchanged
1$50.0%-41.62%
0
Exited
0(-100.0%)$20.0%+57.24%
0
Exited
0(-100.0%)$80.0%-46.23%
0
Exited
0(-100.0%)$55,6530.0%—
0
CNSPCNSPCNS PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used